An Iowa drug developer says it is ready to start an initial round of human testing for a possible vaccine for the deadly Ebola virus.
NewLink Genetics Chief Financial Officer Gordon Link said Thursday the timing of the testing, which would involve up to 100 healthy volunteers, is uncertain.
"We're getting a lot of assistance from a number of sources to accelerate this, so exactly how long it's going to take is a little uncertain because people are greasing the paths as much as they can," Link said.
There is no proven treatment or vaccine for Ebola. The current outbreak of the virus in West Africa is the biggest in history. It has killed more than 1,000 people.